Flexion Therapeutics to Report Second-Quarter 2021 Financial Results on August 4, 2021
Flexion Therapeutics (Nasdaq:FLXN) will release its second-quarter 2021 financial results on August 4, 2021, at 4:30 p.m. ET, after U.S. market close. The company specializes in developing local therapies for musculoskeletal conditions, particularly osteoarthritis. Investors can access a live webcast of the conference call via the Flexion website, and a replay will also be available post-call. For those wishing to ask questions, a dial-in number is provided for both domestic and international participants. Flexion emphasizes values such as focus and ingenuity in its operations.
- None.
- None.
BURLINGTON, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2021 financial results after the close of the U.S. financial markets on Wednesday, August 4, 2021 at 4:30 p.m. ET.
A live webcast of the conference call can be accessed through the “Investors” tab on the Flexion Therapeutics website, and a replay will be available online after the call. For those planning to ask a question, the dial-in number for the conference call is 855-770-0022 for domestic participants and 908-982-4677 for international participants, with Conference ID # 3846257. Please dial in at least 15 minutes in advance to ensure a timely connection to the call.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.
Contact:
Scott Young
Vice President, Corporate Communications & Investor Relations
T: 781-305-7194
syoung@flexiontherapeutics.com
FAQ
When will Flexion Therapeutics report its Q2 2021 financial results?
How can I access the Flexion Therapeutics conference call?
What is Flexion Therapeutics' focus area?
What is the ticker symbol for Flexion Therapeutics?
